Chronic obstructive pulmonary disease (COPD) may increase the risk of osteoporosis and resulting fractures can contribute to disability and mortality of patients. We intended to evaluate the frequency of osteoporosis in male smokers with and without COPD and study whether any correlation existed between osteoporosis and COPD. MATERIALS AND METHODS: This case-control study was carried out in the Department of Medicine, Sylhet M.A.G. Osmani Medical College Hospital, Sylhet, Bangladesh between July 2013 and June 2015. Seventy four male smokers with COPD and 66 age-matched male smokers without COPD were enrolled. All individuals underwent Bone Mass Densitometry (BMD) by Dual-Energy X-Ray Absorptiometry (DEXA). RESULTS: COPD and non-COPD groups did not differ regarding age and smoking pack-years. Osteoporosis at femoral neck (48.6% versus 16.7%; p < 0.001) and lumbar spine (68.9% versus 37.9%; p < 0.01) was significantly higher in COPD compared to controls. Osteopenia did not differ significantly. Patients with COPD were 4.5 times more likely to develop osteoporosis than controls after adjusting age, smoking-pack years and BMI (adjusted OR = 4.5; 95% CI = 1.8-11.5). CONCLUSIONS: Osteoporosis is more frequent in male smokers with COPD compared to smokers without COPD. COPD is a risk factor of osteoporosis independent of age, smoking and BMI.
Introduction 1
Chronic obstructive pulmonary disease (COPD) is a 2 major cause of chronic morbidity and mortality world- limitation is not fully reversible and is associated with 8 an abnormal inflammatory response of the lung to nox-9 ious particles or gases, most often cigarette smoke [1] . 10 In addition to progressive loss of lung function, there 11 is an increasing awareness of the development of extra-12 pulmonary co-morbidities, posing additional problems 13 in the management of COPD [2] . There is a grow-14 
77
Considering an anticipated effect size of 20% and a 78 number of predictors of 4 with 5% significance level 79 and 80% power, the minimum sample size was 65. In 80 this study 74 COPD patients and 66 non-COPD sub-81 jects were enrolled. 
Results

143
The mean age of the COPD group was 62.57 ± 144 8.02 years and of controls 60.65 ± 7.12 years; (p = 145 0.139 NS). The mean smoking pack-years also did not 146 differ significantly (p = 0.118 NS) (Table 1 ). In this 147 study, FEV 1 (% predicted), FVC (% predicted) and 148 FEV 1 /FVC (%) were significantly lower in the COPD 149 group than that of the control group (p < 0.001 each) 150 (Table 2) . GOLD stage-III was the most frequent stage 151 of COPD and constituted 55.4% of the cases, followed 152 by stage-IV (35.1%) and stage-II (9.5%). In the COPD 153 group oral corticosteroids were used by 9 (12.2%) pa-154 tients, inhaled steroids by 47 (63.5%) and 18 (24.3%) 155 patients did not use steroids.
156
Using femoral neck densitometry normal bone min-157 eral density was found significantly fewer in the COPD 158 group than in the controls (8.1% versus 27.3%; p < 159 0.05). Osteoporosis was found significantly more in 160 the COPD group than in the controls (48.6% versus 161 16.7%; p < 0.001); whereas osteopenia did not dif-162 fer significantly between the COPD and control groups 163 (43.2% versus 56.1%; p > 0.05) ( Table 3) .
164
With lumber spinal densitometry normal bone min-165 eral density (5.4% versus 18.2%; p < 0.05) and os-166 u n c o r r e c t e d p r o o f v e r s i o n in patients with COPD when adjusted for age, smoking 181 pack year and BMI (Table 5) . 
Discussion
183
Osteoporosis is a major problem in men with chronic 184 ailments. In men with COPD, osteoporosis may be 185 particularly disabling because vertebral fractures re-186 duce vital capacity, which further compromises venti-187 lation [24] . Evidence suggests that the prevalence of 188 osteoporosis in patients with COPD is high and poten-189 tially important [25, 26] . When studying the relation-190 ship between osteoporosis and COPD, one has to real-191 ize that the two diseases have a number of risk factors 192 in common including: smoking, older age, long-term 193 treatment with corticosteroids, and low body mass in-194 dex.
195
In the current study the mean BMI was significantly 196 lower in the COPD group than in the smoking con-197 trols (p < 0.001) (Table 1) , but with multivariate mul-198 tiple logistic regression analyses BMI did not corre-199 late with osteoporosis (Table 4) . In an Indian uncon-200 trolled study among 102 COPD patients, after using 201 multivariate logistic regression analysis, BMI was not 202 found to be a significant risk factor for osteoporosis 203 [42] , while a treatment of 3 years with inhaled 283 triamcinolone was found to reduce bone mineral den-284 sity [43] . In this study use of oral steroid in COPD pa-285 tients was less than 3 months and this may explain dif-286 ferences with some of the above mentioned studies.
287
In an Indian controlled study among 30 COPD pa-288 tients, the risk of osteoporosis and osteopenia was 289 found to increase with the increase of COPD sever-290 ity [44] . This fits in with our finding that COPD is an 291 independent risk factor for osteoporosis.
292
Our study has some limitations. First, this was a 293 single-centre study. A second limitation is that we did 294 not include X-Ray studies of the vertebra. Third, we 295 did not assess the physical activity of COPD and con-296 trol subjects as this might have influenced osteoporo-297 sis; none of our patients or controls were bed-ridden. 298 Fourth, we did not record the life time cumulative 299 doses of inhaled or systemic corticosteroids.
300
The strength of the study is the fact that it is the 301 first study in Bangladesh and one of the first large con-302 trolled studies in a developing country in Asia study-303 ing the frequency of osteoporosis in smokers with and 304 without COPD. 
